Escalating weekly fixed-dose of nimotuzumab in combination with concurrent chemoradiotherapy in patients with advanced esophageal cancer: A phase I study.
G. Jiang
No relevant relationships to disclose
K. Zhao
No relevant relationships to disclose
S. Yu
No relevant relationships to disclose
X. Chu
No relevant relationships to disclose
P. Liang
No relevant relationships to disclose
J. Zheng
No relevant relationships to disclose